Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
107,482,163
-
Share change
-
+4,949,945
-
Total reported value
-
$1,150,175,758
-
Put/Call ratio
-
58%
-
Price per share
-
$10.69
-
Number of holders
-
192
-
Value change
-
+$45,432,536
-
Number of buys
-
93
-
Number of sells
-
54
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q3 2021
As of 30 Sep 2021,
HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) was held by
192 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
107,482,163 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, BlackRock Inc., UBS OCONNOR LLC, STATE STREET CORP, ArrowMark Colorado Holdings LLC, JPMORGAN CHASE & CO, and PFM Health Sciences, LP.
This page lists
192
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.